CYTOSORBENTS CORPORATION (CTSO) Net income 2016–2025
CYTOSORBENTS CORPORATION (CTSO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.2MFY2025 · since FY2016: -$11.8M → -$8.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.2M | +60.4% |
| FY2024 | -$20.7M | +29.2% |
| FY2023 | -$29.2M | +10.9% |
| FY2022 | -$32.8M | -33.6% |
| FY2021 | -$24.6M | -213.4% |
| FY2020 | -$7.8M | +59.3% |
| FY2019 | -$19.3M | -11.9% |
| FY2018 | -$17.2M | -103.4% |
| FY2017 | -$8.5M | +28.1% |
| FY2016 | -$11.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTSO financial trends
CTSO RevenueCTSO Net marginCTSO Gross profitCTSO Gross marginCTSO Operating incomeCTSO Operating marginCTSO Operating cash flowCTSO Free cash flowCTSO Capital expendituresCTSO Return on equityCTSO Stock buybacksCTSO Dividends paidCTSO Total assetsCTSO Total liabilitiesCTSO Shareholders’ equityCTSO overview →